Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03532360 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Peanut and Tree Nut Desensitization

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jun 26, 2024 to Jun 6, 2025 Show 6 more changesShow less
    • Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre to McGill University Health Centre/Research Institute of the McGill University Health Centre
    • Primary endpoints: details revised at 1 of 2 entries
    • Trial completed
    • Study completion date changed from estimate of Dec 31, 2027 to Jun 6, 2025
    • Eligibility criteria expanded, about 14 words
    • Site details revised at 1 of 2 sites
  2. Minor Enrollment target: 50 to 51
    • Primary completion date changed from estimate of Jan 2, 2024 to Jun 26, 2024
    • Study completion date: Jan 2, 2024 to Dec 31, 2027
    • Secondary endpoints: details revised at 3 of 6 entries
    v8
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
    v7
  4. Minor Eligibility criteria expanded, about 3 wordsv6
  5. Minor Secondary endpoints: details revised at 6 of 6 entriesv5
Show 3 earlier versionsHide 3 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv4
  2. Minor Study sites: 1 to 2
    • Collaborators expanded, about 5 words
    v3
  3. Minor Study description expanded, about 3 wordsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
this study evaluates whether tolerance to peanuts and tree nuts can be induced in patients through a process of oral immunotherapy. Participants will be randomized into groups receiving oral immunotherapy and a control group that will receive no intervention
Trial Details
NCT Number NCT03532360
Lead Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborators: The Hospital for Sick Children
Conditions
(from sponsor)
Peanut Allergy, Tree Nut Allergy
Related terms Nut Hypersensitivity, Peanut Hypersensitivity
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov